Desamino-D-arginine vasopressin in childhood nocturnal enuresis.
The effect of desamino-D-arginine vasopressin was investigated in a double-blind study of 37 children more than 9 years old with nocturnal enuresis resistant to conventional therapy. A significant reduction of wet nights was observed but as soon as the medication was stopped the children reverted to earlier bedwetting habits.
D000293:Adolescent; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D004311:Double-Blind Method; D004775:Enuresis / Q000188:drug therapy*; D006801:Humans; D011897:Random Allocation; D013997:Time Factors
D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin